Granules India Completes USFDA Inspection With Eleven Observations At Gagillapur

Gagillapur finished-dose facility completed USFDA inspection Oct 19-30 with eleven observations, first since February 2025 warning letter. None involved data integrity or cross-contamination, no impact on manufacturing or distribution, response due in 15 business days. Context: warning-letter clearance still pending, extending key overhang.